A Pilot Study of BRS201 in Acute Ulcerative Colitis

Recruiting Phase 2 NCT06420492

Study Description

Study of a Novel Drug for the Treatment of Acute Ulcerative Colitis

Study Details

Registry ID:: NCT06420492
Conditions:: Ulcerative Colitis, Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe
Phase:: Phase 2
Target Enrollment:: 20 participants
Start Date:: September 30, 2025
Age Range:: 18–75 years
Healthy Volunteers:: No

Study Locations (1 site)

Brigham and Women's Hospital
Chestnut Hill, MassachusettsUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →